Background Acute acalculous cholecystitis (AAC) is the most common form of acute cholecystitis in the pediatric population and some cases could have fatal complications. Epstein-Barr virus (EBV) is by far the most knowledgeable viral agent implicated in the pathogenesis of AAC in recent years. Thus, the risk factors in the development of AAC were favorably determined in the settings of EBV hepatitis. Methods Patients below 18 years of age, who had been admitted to Kaohsiung Chang Gung Memorial Hospital and were diagnosed with AAC concomitant with EBV hepatitis between January 2012 and March 2021, were retrospectively analyzed in our study. Our analyses comprised of risk factors including gestational age, age, gender, body weight, history of abdominal surgery, body temperature, duration of fever and hospitalization, clinical presentation, blood test parameters, sonographic findings, and medication. Results The results showed that the mean duration of fever, the presence of ascites, and increased atypical lymphocytes were statistically significant in patients with AAC, symbolizing a more severe disease burden as compared to those without AAC. The presence of ascites in sonographic findings and atypical lymphocytosis over 6.25% may be the two most significant predictive factors of developing AAC in children with EBV hepatitis. Conclusions Our study concluded that children with EBV-related AAC have presented with longer duration of fever, ascites, and atypical lymphocytosis over 6.25%. Further observation and close follow-ups may be suggested in high-risk children to prevent the occurrence of complications that require an emergent operation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.